Microfluidic chip enables single-cell measurement for multidrug resistance in triple-negative breast cancer cells
The role of cell free DNA and liquid biopsies in haematological conditions
Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy
Targeting IKKα kinase to prevent tumor progression and therapy resistance
Reversal of doxorubicin resistance in lung cancer cells by neferine is explained by nuclear factor erythroid-derived 2-like 2 mediated lung resistance protein down regulation
Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel
MicroRNA and liver cancer
Methods for extracellular vesicle isolation from cancer cells
MEK inhibition activates STAT signaling to increase breast cancer immunogenicity via MHC-I expression
The dark side of immunotherapy: pancreatic cancer
Therapeutic modulation of the CD47-SIRPα axis in the pediatric tumor microenvironment: working up an appetite
Therapeutic approaches and drug-resistance in chronic lymphocytic leukaemia
RET kinase alterations in targeted cancer therapy
Biomarkers of resistance to immune checkpoint inhibitors in non-small-cell lung cancer: myth or reality?
Promises and pitfalls of targeted agents in chronic lymphocytic leukemia
Platinum drug sensitivity and resistance in testicular germ cell tumors: two sides of the same coin
Glioblastoma chemoresistance: roles of the mitochondrial melatonergic pathway
Development of a TCR beta repertoire assay for profiling liquid biopsies from NSCLC donors
A review of mechanisms of resistance to immune checkpoint inhibitors and potential strategies for therapy
Resistance to cancer immunotherapy in metastatic renal cell carcinoma
Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance
Can HIPEC be used against platinum-resistance and for inducing sensitivity to PARP inhibitors in ovarian cancer?
Resistance to chemoimmunotherapy in non-small-cell lung cancer
Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma
Pretreatment inflammatory indices predict Bevacizumab response in recurrent Glioma
Drug resistance in glioblastoma: are persisters the key to therapy?
Identification of sequence-specific interactions of the CD44-intracellular domain with RUNX2 in the transcription of matrix metalloprotease-9 in human prostate cancer cells
Nitric oxide-elicited resistance to anti-glioblastoma photodynamic therapy